229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-15.87%
Negative revenue growth signals a shrinking top line, alarming for Benjamin Graham. Confirm if it’s cyclical or structural before proceeding.
-15.71%
Negative gross profit growth suggests either falling sales or rising direct costs. Benjamin Graham would consider this a fundamental warning sign.
-45.91%
Negative EBIT growth points to weakening core profitability. Benjamin Graham would question management efficiency.
-45.91%
Negative operating income growth means rising costs or falling revenues are eroding core profitability. Benjamin Graham would raise caution.
-57.50%
Negative net income growth shows profitability erosion. Benjamin Graham would worry about solvency and longer-term viability.
-58.06%
Negative EPS growth underscores deteriorating earnings per share. Benjamin Graham would worry about ongoing dilution or weakened profitability.
-58.06%
Negative diluted EPS growth suggests diluted shares grew or net income fell. Benjamin Graham would see this as a serious setback to shareholder value.
1.70%
Share count up to +3% – Slight dilution. Howard Marks would be cautious but might accept it if used for profitable growth investments.
1.64%
Diluted share count up to +3% – Modest dilution. Howard Marks might tolerate it if used for high-ROI projects or strategic acquisitions.
-1.67%
A declining dividend or cut can be a serious red flag. Benjamin Graham would check if it signals deeper cash flow problems.
-104.59%
Negative OCF growth is a critical warning sign. Benjamin Graham would check if receivables are ballooning or if core sales are declining.
-126.68%
Negative FCF growth reveals potential liquidity pressures or large capex overshadowing cash generation. Benjamin Graham would demand deeper scrutiny.
435.09%
10Y revenue/share CAGR above 15% – Exceptional long-term expansion. Warren Buffett would confirm if growth is organic, not purely from acquisitions.
78.90%
5Y CAGR above 15% – Robust mid-term revenue/share growth. Warren Buffett might ensure net margins are rising alongside top-line expansions.
32.67%
3Y CAGR above 15% – Rapid short-term revenue/share growth. Warren Buffett would see if margins are stable, ensuring profitable expansion.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
4.15%
3Y OCF/share CAGR 2-5% – Mild. Peter Lynch would look for near-term catalysts to accelerate OCF further.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-86.77%
Negative 3Y net income/share CAGR highlights recent bottom-line decay. Benjamin Graham would want clarity on cost vs. revenue drivers for the declines.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
18.63%
3Y equity/share CAGR above 12% – Excellent recent net worth expansion. Warren Buffett would check consistent earnings retention or beneficial buybacks driving this growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1.33%
3Y dividend/share CAGR 0-2% – Barely rising. Howard Marks might worry about tight margins or conservative policies limiting payouts.
7.63%
Receivables growth 0-10% – Typically normal if revenue grows at a similar pace. Seth Klarman verifies the AR-to-revenue ratio stays constant.
-3.89%
Negative inventory growth can boost near-term margins if sales remain stable. Benjamin Graham still checks that it’s not from falling demand.
4.83%
Asset growth 0-5% – Minimal. Howard Marks notes the firm may be optimizing existing assets or being cautious with expansions.
1.00%
0-2% annual BV/share growth – Minimal. Howard Marks worries about near-stagnant net worth accumulation.
5.76%
Debt up 5-10% yoy – Noticeable leverage. Howard Marks questions if the returns outstrip higher interest costs.
-12.20%
A big drop in R&D might boost near-term earnings but risk starving the pipeline. Benjamin Graham sees if the firm is refocusing or if future growth suffers.
-11.93%
Shrinking SG&A can raise profits short term, but might risk cutting key growth drivers. Benjamin Graham sees if this is sustainable.
